SELECT FROM MENU

Therapy Area
Drug Classes

       Disease Area

All Sessions

All Sessions

All Sessions

Resectable NSCLC

All Sessions

Metastatic NSCLC

All Sessions

SCLC

All Sessions

Biomarkers

       Drug Class

Targeted Therapies

Targeted Therapies

Immuno-therapies

Immuno-therapies

Antibody-Drug Conjugates

Antibody-Drug Conjugates

Anne-Marie Dingemans

Anne-Marie Dingemans

Erasmus MC, Rotterdam

Prof. Anne-Marie Dingemans is professor of thoracic oncology and a pulmonologist in the Department of Pulmonary Medicine at Erasmus MC, Rotterdam. Her translational lung cancer research focuses on neuroendocrine tumors, oligometastatic disease, and driver mutations, and she has co-authored more than 200 publications spanning targeted therapy and immunotherapy in non-small cell and small cell lung cancer. She is a former chair of the EORTC Lung Cancer Group and is an associate editor of the Journal of Thoracic Oncology, as well as a frequent speaker at major international lung cancer congresses.

Connect

Anne-Marie Dingemans

Featured in

Indication Areas

All Sessions

All Sessions

Resectable NSCLC

Resectable NSCLC

Metastatic Lung Cancer

Metastatic NSCLC

Lung Cancer

SCLC

Biomarkers

Biomarkers & Diagnostics

DRUG CLASSES

Pill

Targeted Therapies

OncoNews

Immunotherapies

Antibody Drug Conjugates

Antibody-Drug Conjugates